Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Battle Lines Clear On Conflict Of Interest Policy In PDUFA Reauthorization

This article was originally published in The Tan Sheet

Executive Summary

Commissioner Hamburg says the agency likely does not need legislation to improve its conflict of interest policy, but House members still say the system needs reform. Industry and patient advocate groups push for change, while consumer groups press FDA to stand firm.

You may also be interested in...



FDA Budget Proposal Shifts More Toward User Fees Reliance

User fees make up the bulk of FDA’s human drug spending under President Obama’s fiscal 2014 budget proposal, a trend fueled by new user fee programs and cuts to taxpayer funding.

FDA Budget Proposal Shifts More Toward User Fees Reliance

User fees make up the bulk of FDA’s human drug spending under President Obama’s fiscal 2014 budget proposal, a trend fueled by new user fee programs and cuts to taxpayer funding.

FDA IT Systems In Senate Appropriators’ Crosshairs

The Senate Appropriations Committee approves a $3.9 billion spending plan for the agency in fiscal 2013, providing a $12.5 million boost in direct funding over President Obama’s proposed budget, with the extra funds slated for the food and animal drug programs.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

ID1131849

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel